Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00936364 · ClinicalTrials.gov registry record · NA
Short-Term Fasting: Impact on Toxicity
A NA study, sponsored by University of Southern California.
- Terminated
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT00936364 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 47 participants.
The verdict
NCT00936364, a NA study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
This partially randomized clinical trial studies short-term fasting in reducing side effects in patients receiving gemcitabine hydrochloride and cisplatin for advanced solid tumors. Short-term fasting before chemotherapy may reduce the side effects caused by chemotherapy. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Interventions
- OTHER Fasting
- OTHER Short-term fasting
- OTHER Modified fast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2009-07-09 |
| Est. Completion | 2025-05-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00936364
The ClinicalTrials.gov registry entry for NCT00936364 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Fasting is the first listed.
NCT00936364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00936364 about?
NCT00936364 is a clinical study titled "Short-Term Fasting: Impact on Toxicity". This partially randomized clinical trial studies short-term fasting in reducing side effects in patients receiving gemcitabine hydrochloride and cisplatin for advanced solid tumors. Short-term fasting before chemotherapy may reduce the side effects caused by chemotherapy. Drugs used in chemotherapy,...
What is the current status of trial NCT00936364?
This trial is currently terminated. It is a NA study. The enrollment target is 47 participants. The study started on 2009-07-09. Estimated completion is 2025-05-23.
What interventions are being tested in trial NCT00936364?
The interventions under investigation include: Fasting (OTHER), Short-term fasting (OTHER), Modified fast (OTHER).
Who is sponsoring clinical trial NCT00936364?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.